<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-118281</identifier>
<setSpec>1575-0922</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">No disponible</dc:title>
<dc:creator>Perez, Antonio</dc:creator>
<dc:language>es</dc:language>
<dc:source>Endocrinol Nutr;57(10): 457-459, dic. 2010.</dc:source>
<dc:identifier>ibc-118281</dc:identifier>
<dc:title xml:lang="es">¿Debemos modificar el tratamiento de la dislipemia diabética después del estudio de lípidos del Action to Control Cardiovascular Risk in Diabetes?</dc:title>
<dc:subject>^d29633</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d2359^s22054</dc:subject>
<dc:subject>^d33014^s22073</dc:subject>
<dc:subject>^d50514^s22057</dc:subject>
<dc:subject>^d54030^s22073</dc:subject>
<dc:subject>^d3942^s22057</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:type>article</dc:type>
<dc:date>201012</dc:date>
</metadata>
</record>
</ibecs-document>
